AVACINCAPTAD PEGOL

AVACINCAPTAD PEGOL was reported 352 times

AVACINCAPTAD PEGOL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 OCULOCARDIAC REFLEX 3 0.1875
1 INADEQUATE ASEPTIC TECHNIQUE IN MANUFACTURING OF PRODUCT 1 0.1250
2 BULLOUS KERATOPATHY 1 0.0714
3 MACULAR CYST 3 0.0357
4 PSEUDOPHAKIA 2 0.0230
5 INADEQUATE ASEPTIC TECHNIQUE IN USE OF PRODUCT 7 0.0193
6 CHOROIDAL NEOVASCULARISATION 15 0.0175
7 LOSS OF VISUAL CONTRAST SENSITIVITY 1 0.0159
8 HAEMORRHAGIC OCCLUSIVE RETINAL VASCULITIS 1 0.0137
9 RETINAL OCCLUSIVE VASCULITIS 3 0.0134
10 OCULAR VASCULITIS 2 0.0116
11 BACTERIAL ENDOPHTHALMITIS 3 0.0113
12 EYE INFARCTION 1 0.0100
13 VITREAL CELLS 2 0.0099
14 INTRA-OCULAR INJECTION COMPLICATION 2 0.0088
15 EYE NAEVUS 1 0.0088
16 NON-INFECTIOUS ENDOPHTHALMITIS 7 0.0082
17 VITRITIS 13 0.0070
18 VITREOUS HAZE 1 0.0065
19 EYE EXCISION 1 0.0049
20 HYPOTONY OF EYE 2 0.0048
21 ANTERIOR CHAMBER FLARE 1 0.0043
22 INTRAOCULAR PRESSURE TEST 1 0.0042
23 RETINAL INFARCTION 1 0.0041
24 DRY AGE-RELATED MACULAR DEGENERATION 4 0.0036
25 PRODUCT CLOSURE ISSUE 2 0.0036
26 NEOVASCULAR AGE-RELATED MACULAR DEGENERATION 5 0.0036
27 RETINAL ISCHAEMIA 2 0.0033
28 VISUAL ACUITY REDUCED TRANSIENTLY 1 0.0032
29 PRODUCT TEMPERATURE EXCURSION ISSUE 16 0.0031
30 CHORIORETINITIS 2 0.0031
31 INTERCEPTED PRODUCT STORAGE ERROR 11 0.0031
32 PACKAGING DESIGN ISSUE 1 0.0030
33 IRITIS 9 0.0030
34 CHOROIDITIS 1 0.0027
35 ENDOPHTHALMITIS 16 0.0027
36 CYSTOID MACULAR OEDEMA 5 0.0027
37 PRODUCT CONTAMINATION 9 0.0025
38 RETINAL VASCULITIS 3 0.0025
39 DYSCHROMATOPSIA 2 0.0024
40 VITREOUS OPACITIES 2 0.0024
41 CORNEAL OEDEMA 5 0.0022
42 PRODUCT OUTER PACKAGING ISSUE 2 0.0022
43 VITREOUS DISORDER 1 0.0021
44 OCULAR HYPERTENSION 4 0.0021
45 INTERCEPTED PRODUCT PREPARATION ERROR 25 0.0020
46 PRODUCT PACKAGING DIFFICULT TO OPEN 5 0.0019
47 BLINDNESS TRANSIENT 13 0.0018
48 OPEN ANGLE GLAUCOMA 1 0.0016
49 PRODUCT CONTAMINATION PHYSICAL 4 0.0016
50 NECROTISING RETINITIS 1 0.0016
51 RETINAL DEGENERATION 2 0.0015
52 CATARACT NUCLEAR 1 0.0015
53 EYE INFLAMMATION 14 0.0015
54 CORNEAL ABRASION 2 0.0015
55 EPISCLERITIS 1 0.0014
56 INTRAOCULAR PRESSURE TEST ABNORMAL 1 0.0014
57 ANTERIOR CHAMBER CELL 1 0.0014
58 VITREOUS DETACHMENT 3 0.0014
59 CHROMATOPSIA 1 0.0013
60 OPTIC ISCHAEMIC NEUROPATHY 5 0.0013
61 EYE OEDEMA 3 0.0012
62 HYPOPYON 1 0.0012
63 GIANT CELL ARTERITIS 1 0.0012
64 INTRAOCULAR PRESSURE INCREASED 15 0.0012
65 VITREOUS FLOATERS 11 0.0011
66 RETINAL OEDEMA 2 0.0010
67 INTERCEPTED PRODUCT ADMINISTRATION ERROR 8 0.0010
68 SYRINGE ISSUE 18 0.0010
69 SUSPECTED PRODUCT CONTAMINATION 1 0.0010
70 CONJUNCTIVAL OEDEMA 1 0.0010
71 PRODUCT PACKAGING ISSUE 9 0.0009
72 EXOPHTHALMOS 2 0.0009
73 OCULAR TOXICITY 1 0.0009
74 PRODUCT PACKAGE ASSOCIATED INJURY 2 0.0009
75 SUSPECTED OFF LABEL USE 4 0.0009
76 UVEITIS 12 0.0009
77 NEEDLE ISSUE 23 0.0008
78 HERPES OPHTHALMIC 1 0.0008
79 INTERCEPTED PRODUCT PRESCRIBING ERROR 1 0.0008
80 RETINAL VEIN OCCLUSION 2 0.0007
81 GENERALISED ANXIETY DISORDER 1 0.0007
82 EYE ALLERGY 1 0.0006
83 IRIDOCYCLITIS 2 0.0006
84 PHOTOPSIA 4 0.0006
85 RETINAL THICKENING 1 0.0006
86 PRODUCT CONTAINER SEAL ISSUE 1 0.0006
87 STAPHYLOCOCCUS TEST POSITIVE 1 0.0005
88 OPTIC NEUROPATHY 1 0.0005
89 INTERCEPTED MEDICATION ERROR 2 0.0004
90 EYE PAIN 24 0.0004
91 RETINAL HAEMORRHAGE 3 0.0004
92 POOR QUALITY PRODUCT ADMINISTERED 4 0.0004
93 EYE INFECTION 4 0.0004
94 EYELID MARGIN CRUSTING 1 0.0003
95 GRIP STRENGTH DECREASED 3 0.0003
96 KERATITIS 1 0.0003
97 EYE HAEMORRHAGE 4 0.0003
98 HAEMORRHAGIC DIATHESIS 1 0.0003
99 CONJUNCTIVAL HYPERAEMIA 1 0.0003
100 SKIN WEEPING 1 0.0003
101 LIQUID PRODUCT PHYSICAL ISSUE 2 0.0003
102 VISUAL ACUITY REDUCED 9 0.0003
103 PANIC DISORDER 1 0.0003
104 BLEPHARITIS 1 0.0002
105 ATTENTION DEFICIT HYPERACTIVITY DISORDER 1 0.0002
106 PRODUCT CONTAINER ISSUE 2 0.0002
107 ABNORMAL SENSATION IN EYE 1 0.0002
108 MELANOCYTIC NAEVUS 1 0.0002
109 CHRONIC LYMPHOCYTIC LEUKAEMIA 1 0.0002
110 VISUAL IMPAIRMENT 26 0.0002
111 DIZZINESS POSTURAL 2 0.0002
112 FOOT OPERATION 1 0.0002
113 EYE DISCHARGE 2 0.0002
114 INJECTION SITE DISCHARGE 1 0.0002
115 PRODUCT RESIDUE PRESENT 1 0.0002
116 MACULAR DEGENERATION 2 0.0002
117 VISION BLURRED 22 0.0002
118 BLEPHAROSPASM 1 0.0002
119 FOREIGN BODY SENSATION IN EYES 1 0.0002
120 GLAUCOMA 3 0.0002
121 EYE DISORDER 5 0.0002
122 OCULAR HYPERAEMIA 7 0.0001
123 BLINDNESS UNILATERAL 2 0.0001
124 EYE IRRITATION 8 0.0001
125 PRODUCT STORAGE ERROR 12 0.0001
126 NO ADVERSE EVENT 24 0.0001
127 DEVICE ISSUE 11 0.0001
128 EYE PRURITUS 4 0.0001
129 IMMUNOSUPPRESSION 1 0.0001
130 FACIAL PAIN 1 0.0001
131 INCREASED TENDENCY TO BRUISE 1 0.0001
132 LACRIMATION INCREASED 3 0.0001
133 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 1 0.0001
134 SKIN LACERATION 1 0.0001
135 OCULAR DISCOMFORT 1 0.0001
136 IMPAIRED DRIVING ABILITY 1 0.0001
137 DERMATITIS CONTACT 1 0.0001
138 SCAB 1 0.0001
139 MADAROSIS 1 0.0001
140 EYELID OEDEMA 1 0.0001
141 CYST 1 0.0001
142 MYDRIASIS 1 0.0001
143 HIATUS HERNIA 1 0.0001
144 SEDATION 2 0.0001
145 BLINDNESS 3 0.0001
146 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 13 0.0001
147 INTENTIONAL DOSE OMISSION 2 0.0001
148 HYPOAESTHESIA ORAL 1 0.0001
149 DEVICE FAILURE 1 0.0001
150 THERAPY PARTIAL RESPONDER 1 0.0001
151 PHOTOSENSITIVITY REACTION 1 0.0001
152 DRUG LEVEL INCREASED 1 0.0001
153 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 1 0.0001
154 THIRST 1 0.0001
155 CONJUNCTIVITIS 1 0.0001
156 EYE SWELLING 2 0.0001
157 PHOTOPHOBIA 1 0.0001
158 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
159 INJURY ASSOCIATED WITH DEVICE 1 0.0000
160 KNEE ARTHROPLASTY 1 0.0000
161 HALLUCINATION, VISUAL 1 0.0000
162 SKIN CANCER 1 0.0000
163 PRODUCT PRESCRIBING ISSUE 1 0.0000
164 COGNITIVE DISORDER 2 0.0000
165 DRY EYE 2 0.0000
166 SKIN ULCER 1 0.0000
167 DEAFNESS 1 0.0000
168 WOUND 1 0.0000
169 LETHARGY 2 0.0000
170 CATARACT 2 0.0000
171 CONDITION AGGRAVATED 10 0.0000
172 NIGHT SWEATS 1 0.0000
173 LIP SWELLING 1 0.0000
174 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
175 HEART RATE DECREASED 1 0.0000
176 UNDERDOSE 2 0.0000
177 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
178 PLASMA CELL MYELOMA 1 0.0000
179 OFF LABEL USE 22 0.0000
180 CONFUSIONAL STATE 4 0.0000
181 EXTRA DOSE ADMINISTERED 1 0.0000
182 POLLAKIURIA 1 0.0000
183 TINNITUS 1 0.0000
184 DISEASE RECURRENCE 1 0.0000
185 RASH ERYTHEMATOUS 1 0.0000
186 SOMNOLENCE 4 0.0000
187 OEDEMA 1 0.0000
188 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
189 ANAPHYLACTIC REACTION 1 0.0000
190 MEDICATION ERROR 1 0.0000
191 NECK PAIN 1 0.0000
192 HERPES ZOSTER 1 0.0000
193 CHILLS 2 0.0000
194 DISEASE PROGRESSION 2 0.0000
195 WHEEZING 1 0.0000
196 IRRITABILITY 1 0.0000
197 THERAPEUTIC RESPONSE DECREASED 1 0.0000
198 DISCOMFORT 1 0.0000
199 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
200 AMNESIA 1 0.0000
201 BLOOD PRESSURE DECREASED 1 0.0000
202 NEOPLASM MALIGNANT 1 0.0000
203 HYPOTENSION 3 0.0000
204 INJECTION SITE PRURITUS 1 0.0000
205 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 3 0.0000
206 PRODUCT QUALITY ISSUE 2 0.0000
207 HEPATIC ENZYME INCREASED 1 0.0000
208 INJECTION SITE REACTION 1 0.0000
209 THERAPY INTERRUPTED 1 0.0000
210 URTICARIA 2 0.0000
211 SKIN EXFOLIATION 1 0.0000
212 BALANCE DISORDER 1 0.0000
213 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
214 HEADACHE 7 0.0000
215 HYPERSENSITIVITY 2 0.0000
216 PULMONARY EMBOLISM 1 0.0000
217 CHEST DISCOMFORT 1 0.0000
218 RHEUMATOID ARTHRITIS 1 0.0000
219 PALPITATIONS 1 0.0000
220 FEELING ABNORMAL 2 0.0000
221 LOSS OF CONSCIOUSNESS 1 0.0000
222 COUGH 2 0.0000
223 PRODUCT DOSE OMISSION ISSUE 2 0.0000
224 HYPOAESTHESIA 1 0.0000
225 INJECTION SITE PAIN 2 0.0000
226 TREMOR 1 0.0000
227 DEATH 5 0.0000
228 NASOPHARYNGITIS 1 0.0000
229 DRUG INEFFECTIVE 7 0.0000
230 HYPERTENSION 1 0.0000
231 WEIGHT INCREASED 1 0.0000
232 DEPRESSION 1 0.0000
233 INCORRECT DOSE ADMINISTERED 1 0.0000
234 FATIGUE 3 0.0000
235 WEIGHT DECREASED 1 0.0000
236 PAIN 2 0.0000
237 DIARRHOEA 2 0.0000
238 ASTHENIA 1 0.0000
239 PRURITUS 1 0.0000
240 ARTHRALGIA 1 0.0000
241 MALAISE 1 0.0000
242 VOMITING 1 0.0000
243 DIZZINESS 1 0.0000
244 DYSPNOEA 1 0.0000